Clinical Roundup Five genes linked to aggressive prostate cancer in men of African descent, USC study identifies November 07, 2025Vol.51 No.41
Clinical Roundup Some p53 mutations could help fight cancer, Baylor study finds November 07, 2025Vol.51 No.41
Drugs & Targets FDA approves Darzalex Faspro for high-risk smoldering multiple myeloma November 07, 2025Vol.51 No.41
Drugs & Targets GSK, Empirico enter license agreement for oligonucleotide candidate to treat respiratory diseases November 07, 2025Vol.51 No.41
Drugs & Targets EMA grants GSK’227 Orphan Drug Designation for pulmonary neuroendocrine carcinoma November 07, 2025Vol.51 No.41
NCINews Analysis Cancer centers adapt to life without site visits as NIH changes CCSG review October 31, 2025Vol.51 No.40By Paul Goldberg
Class action complaint alleging GRAIL insider fraud resubmitted after dismissal October 31, 2025Vol.51 No.40By Jacquelyn Cobb
Trials & Tribulations How GLP-1RA drugs are reshaping patient physiology and the future of oncology October 31, 2025Vol.51 No.40By Deborah Phippard
